» Articles » PMID: 20676319

Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007

Overview
Specialty General Medicine
Date 2010 Aug 3
PMID 20676319
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer has been the leading cause of death in Korea. Korea is facing a very rapid change and increase in cancer incidence, which draws much attention in public health. This paper overviews the nationwide cancer statistics, including incidence, mortality, and survival rates, and their trends in Korea based on the cancer incidence data from The Korea Central Cancer Registry (KCCR) in year 2006 and 2007. In Korea, there were 153,237 cancer cases and 65,519, cancer deaths observed in 2006, and 161,920 cancer cases and 67,561 cancer deaths in 2007, respectively. The incidence rate for all cancer combined showed an annual increase of 2.8% from 1999 to 2007. Specifically, there was significant increase in the incidence of colorectal, thyroid, female breast, and prostate cancers. The number of cancer deaths has increased over the past two decades, due mostly to population aging, while the age-standardized mortality rates have decreased in both men and women since 2002. Notable improvement has been observed in the 5-yr relative survival rates for most major cancers and for all cancer combined, with the exception of pancreatic cancer. The nationwide cancer statistics in this paper will provide essential data for cancer research and evidence-based health policy in Korea.

Citing Articles

Associations between Diabetes Mellitus and Selected Cancers.

Pliszka M, Szablewski L Int J Mol Sci. 2024; 25(13).

PMID: 39000583 PMC: 11242587. DOI: 10.3390/ijms25137476.


Gastric cancer surgery in South Korea: Past, present, and future.

Kim S, Lee S, Eom B, Yoon H, Kim Y, Ryu K Chin J Cancer Res. 2024; 35(6):627-635.

PMID: 38204450 PMC: 10774143. DOI: 10.21147/j.issn.1000-9604.2023.06.07.


Laparoscopic systemic restaging surgery for women with unexpected uterine malignancy.

Kim E, Hong H, Lee W, Choi J, Bae J, Jung U Obstet Gynecol Sci. 2022; 65(6):522-530.

PMID: 36414231 PMC: 9683930. DOI: 10.5468/ogs.22236.


Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019.

Park J, Moon K, Kim D Front Oncol. 2022; 12:862173.

PMID: 35832556 PMC: 9271972. DOI: 10.3389/fonc.2022.862173.


Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets.

Khan M, Prajapati B, Lakhina S, Sharma M, Prajapati S, Chosdol K Front Oncol. 2021; 11:699594.

PMID: 34621669 PMC: 8491982. DOI: 10.3389/fonc.2021.699594.


References
1.
Jung K, Yim S, Kong H, Hwang S, Won Y, Lee J . Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci. 2007; 22 Suppl:S5-S10. PMC: 2694370. DOI: 10.3346/jkms.2007.22.S.S5. View

2.
Won Y, Sung J, Jung K, Kong H, Park S, Shin H . Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009; 41(3):122-31. PMC: 2757659. DOI: 10.4143/crt.2009.41.3.122. View

3.
Enewold L, Zhu K, Ron E, Marrogi A, Stojadinovic A, Peoples G . Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009; 18(3):784-91. PMC: 2676561. DOI: 10.1158/1055-9965.EPI-08-0960. View

4.
Davies L, Welch H . Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164-7. DOI: 10.1001/jama.295.18.2164. View

5.
Dickman P, Adami H . Interpreting trends in cancer patient survival. J Intern Med. 2006; 260(2):103-17. DOI: 10.1111/j.1365-2796.2006.01677.x. View